Related Experiment Video
Updated: Jan 2, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
It Takes Two (Genomes) to Cancer: Paired Viral and Host Transcriptome Analysis Provides New Insights about EBV
Sam M Mbulaiteye1, Ludmila Prokunina-Olsson2
1Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland.
Abstract:
The discovery of Epstein-Barr virus (EBV) in 1964 gave birth to the field of viral oncology. Despite significant scientific and clinical developments in research on several other viruses discovered and linked to cancer risk much later, our understanding of EBV as a carcinogen and a possible target for therapeutic interventions remains limited. In this issue of Cancer Research, Chakravorty and colleagues present results of massive reanalysis of public RNA-sequencing data for 291 control and 1,051 tumor samples representing 15 cancer types. Their paired analysis of the viral and host transcriptome sheds light on mechanisms of EBV carcinogenicity and provides new leads for translational applications.See related article by Chakravorty et al., p. 6010.
Insights
Epstein-Barr virus (EBV) research is advancing. A new analysis of RNA sequencing data reveals insights into EBV
Area of Science:
- Viral oncology
- Cancer research
- Molecular biology
Background:
- Epstein-Barr virus (EBV) discovery in 1964 initiated viral oncology.
- Understanding EBV's role as a carcinogen and therapeutic target remains limited despite advances in other oncogenic viruses.
- Significant scientific and clinical developments have occurred in research on other viruses linked to cancer risk.
Purpose of the Study:
- To reanalyze public RNA-sequencing data to understand EBV carcinogenicity mechanisms.
- To identify new leads for translational applications targeting EBV in cancer.
- To investigate the interplay between the viral and host transcriptome in EBV-associated cancers.
Main Methods:
- Massive reanalysis of public RNA-sequencing data.
- Analysis of 291 control and 1,051 tumor samples across 15 cancer types.
- Paired analysis of viral and host transcriptome.
Main Results:
- The study provides a comprehensive analysis of EBV's impact on the host transcriptome.
- New insights into the molecular mechanisms underlying EBV-driven carcinogenesis were uncovered.
- Identification of potential therapeutic targets and biomarkers for EBV-associated cancers.
Conclusions:
- The findings enhance our understanding of EBV carcinogenicity.
- The study offers novel avenues for developing targeted therapies against EBV-associated malignancies.
- This research provides a foundation for future translational applications in viral oncology.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Viruses with RNA Genomes
Retrovirus Life Cycles

